Information Provided By: 
Fly News Breaks for April 27, 2018
SPLK
Apr 27, 2018 | 07:25 EDT
As previously reported, Wedbush analyst Steve Koenig upgraded Splunk to Outperform from Neutral, stating that his CISO conversations at the RSA security conference pointed to the company's emergence as a key security platform and "must-have" for modern enterprises. Given the stock's recent pullback, as well as his outlook for operating margin expansion and minimal revenue deceleration from CY19 to CY20, Koenig sees this as a attractive time to enter the stock, he tells investors. He raised his price target on Splunk shares to $118 from $103.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
